Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
ALK-positive Non-small Cell Lung Cancer
Chengdu, Sichuan
ALK-positive Non-small Cell Lung Cancer Clinical Trials in Chengdu, Sichuan
1 recruiting
Chengdu, Sichuan, China
Showing
1–1
of
1
trials
Recruiting
Real World Study of Lolatinib for Advanced ALK+ NSCLC Patients
Real World Study
ALK-positive Non-small Cell Lung Cancer
Sichuan Cancer Hospital and Research Institute
200 enrolled
1 location
NCT06361589
Feedback